aluates Reports

$ 0.0

Automative

Global Gene Therapies for Tumor Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-4D14276

Global Gene Therapies for Tumor Treatment Market Research Report 2023

BUY CHAPTERS

Global Gene Therapies for Tumor Treatment Market Research Report 2024

Code: QYRE-Auto-4D14276

Report

January 2024

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gene Therapies for Tumor Treatment Market Size

The global Gene Therapies for Tumor Treatment market was valued at US$ 4915 million in 2023 and is anticipated to reach US$ 20270 million by 2030, witnessing a CAGR of 20.1% during the forecast period 2024-2030.

Gene Therapies for Tumor Treatment Market

Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.

The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.

This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Tumor Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Tumor Treatment.

Report Scope

The Gene Therapies for Tumor Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapies for Tumor Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapies for Tumor Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapies for Tumor Treatment Market Report

Report Metric	Details
Report Name	Gene Therapies for Tumor Treatment Market
Accounted market size in 2023	US$ 4915 million
Forecasted market size in 2030	US$ 20270 million
CAGR	20.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Gene Induced Immunotherapy Oncolytic Virotherapy Gene Transfer
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead Sciences, Amgen, Shanghai Sunway, Sibiono
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Tumor Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Therapies for Tumor Treatment Market growing?

Ans: The Gene Therapies for Tumor Treatment Market witnessing a CAGR of 20.1% during the forecast period 2024-2030.

What is the Gene Therapies for Tumor Treatment Market size in 2030?

Ans: The Gene Therapies for Tumor Treatment Market size in 2030 will be US$ 20270 million.

Who are the main players in the Gene Therapies for Tumor Treatment Market report?

Ans: The main players in the Gene Therapies for Tumor Treatment Market are Novartis, Gilead Sciences, Amgen, Shanghai Sunway, Sibiono

What are the Application segmentation covered in the Gene Therapies for Tumor Treatment Market report?

Ans: The Applications covered in the Gene Therapies for Tumor Treatment Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Gene Therapies for Tumor Treatment Market report?

Ans: The Types covered in the Gene Therapies for Tumor Treatment Market report are Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Gene Induced Immunotherapy

1.2.3 Oncolytic Virotherapy

1.2.4 Gene Transfer

1.3 Market by Application

1.3.1 Global Gene Therapies for Tumor Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapies for Tumor Treatment Market Perspective (2019-2030)

2.2 Gene Therapies for Tumor Treatment Growth Trends by Region

2.2.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene Therapies for Tumor Treatment Historic Market Size by Region (2019-2024)

2.2.3 Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2025-2030)

2.3 Gene Therapies for Tumor Treatment Market Dynamics

2.3.1 Gene Therapies for Tumor Treatment Industry Trends

2.3.2 Gene Therapies for Tumor Treatment Market Drivers

2.3.3 Gene Therapies for Tumor Treatment Market Challenges

2.3.4 Gene Therapies for Tumor Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue

3.1.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue (2019-2024)

3.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapies for Tumor Treatment Revenue

3.4 Global Gene Therapies for Tumor Treatment Market Concentration Ratio

3.4.1 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2023

3.5 Gene Therapies for Tumor Treatment Key Players Head office and Area Served

3.6 Key Players Gene Therapies for Tumor Treatment Product Solution and Service

3.7 Date of Enter into Gene Therapies for Tumor Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapies for Tumor Treatment Breakdown Data by Type

4.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Type (2019-2024)

4.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2025-2030)

5 Gene Therapies for Tumor Treatment Breakdown Data by Application

5.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Application (2019-2024)

5.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene Therapies for Tumor Treatment Market Size (2019-2030)

6.2 North America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)

6.4 North America Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapies for Tumor Treatment Market Size (2019-2030)

7.2 Europe Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)

7.4 Europe Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapies for Tumor Treatment Market Size (2019-2030)

8.2 Asia-Pacific Gene Therapies for Tumor Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapies for Tumor Treatment Market Size (2019-2030)

9.2 Latin America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)

9.4 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapies for Tumor Treatment Market Size (2019-2030)

10.2 Middle East & Africa Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Gene Therapies for Tumor Treatment Introduction

11.1.4 Novartis Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Detail

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Introduction

11.2.4 Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)

11.2.5 Gilead Sciences Recent Development

11.3 Amgen

11.3.1 Amgen Company Detail

11.3.2 Amgen Business Overview

11.3.3 Amgen Gene Therapies for Tumor Treatment Introduction

11.3.4 Amgen Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)

11.3.5 Amgen Recent Development

11.4 Shanghai Sunway

11.4.1 Shanghai Sunway Company Detail

11.4.2 Shanghai Sunway Business Overview

11.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Introduction

11.4.4 Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)

11.4.5 Shanghai Sunway Recent Development

11.5 Sibiono

11.5.1 Sibiono Company Detail

11.5.2 Sibiono Business Overview

11.5.3 Sibiono Gene Therapies for Tumor Treatment Introduction

11.5.4 Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2019-2024)

11.5.5 Sibiono Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Gene Induced Immunotherapy

Table 3. Key Players of Oncolytic Virotherapy

Table 4. Key Players of Gene Transfer

Table 5. Global Gene Therapies for Tumor Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gene Therapies for Tumor Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Gene Therapies for Tumor Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Gene Therapies for Tumor Treatment Market Share by Region (2019-2024)

Table 9. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Gene Therapies for Tumor Treatment Market Share by Region (2025-2030)

Table 11. Gene Therapies for Tumor Treatment Market Trends

Table 12. Gene Therapies for Tumor Treatment Market Drivers

Table 13. Gene Therapies for Tumor Treatment Market Challenges

Table 14. Gene Therapies for Tumor Treatment Market Restraints

Table 15. Global Gene Therapies for Tumor Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Gene Therapies for Tumor Treatment Market Share by Players (2019-2024)

Table 17. Global Top Gene Therapies for Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2023)

Table 18. Ranking of Global Top Gene Therapies for Tumor Treatment Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Gene Therapies for Tumor Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Gene Therapies for Tumor Treatment Product Solution and Service

Table 22. Date of Enter into Gene Therapies for Tumor Treatment Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Therapies for Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2019-2024)

Table 26. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2025-2030)

Table 28. Global Gene Therapies for Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2019-2024)

Table 30. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2025-2030)

Table 32. North America Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Gene Therapies for Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Gene Therapies for Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Gene Therapies for Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Gene Therapies for Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Gene Therapies for Tumor Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Gene Therapies for Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Gene Therapies for Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. Novartis Company Detail

Table 48. Novartis Business Overview

Table 49. Novartis Gene Therapies for Tumor Treatment Product

Table 50. Novartis Revenue in Gene Therapies for Tumor Treatment Business (2019-2024) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Gilead Sciences Company Detail

Table 53. Gilead Sciences Business Overview

Table 54. Gilead Sciences Gene Therapies for Tumor Treatment Product

Table 55. Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2019-2024) & (US$ Million)

Table 56. Gilead Sciences Recent Development

Table 57. Amgen Company Detail

Table 58. Amgen Business Overview

Table 59. Amgen Gene Therapies for Tumor Treatment Product

Table 60. Amgen Revenue in Gene Therapies for Tumor Treatment Business (2019-2024) & (US$ Million)

Table 61. Amgen Recent Development

Table 62. Shanghai Sunway Company Detail

Table 63. Shanghai Sunway Business Overview

Table 64. Shanghai Sunway Gene Therapies for Tumor Treatment Product

Table 65. Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2019-2024) & (US$ Million)

Table 66. Shanghai Sunway Recent Development

Table 67. Sibiono Company Detail

Table 68. Sibiono Business Overview

Table 69. Sibiono Gene Therapies for Tumor Treatment Product

Table 70. Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2019-2024) & (US$ Million)

Table 71. Sibiono Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Therapies for Tumor Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gene Therapies for Tumor Treatment Market Share by Type: 2023 VS 2030

Figure 3. Gene Induced Immunotherapy Features

Figure 4. Oncolytic Virotherapy Features

Figure 5. Gene Transfer Features

Figure 6. Global Gene Therapies for Tumor Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Gene Therapies for Tumor Treatment Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Other Case Studies

Figure 11. Gene Therapies for Tumor Treatment Report Years Considered

Figure 12. Global Gene Therapies for Tumor Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Gene Therapies for Tumor Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Gene Therapies for Tumor Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Gene Therapies for Tumor Treatment Market Share by Players in 2023

Figure 16. Global Top Gene Therapies for Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Gene Therapies for Tumor Treatment Revenue in 2023

Figure 18. North America Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Gene Therapies for Tumor Treatment Market Share by Country (2019-2030)

Figure 20. United States Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Gene Therapies for Tumor Treatment Market Share by Country (2019-2030)

Figure 24. Germany Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapies for Tumor Treatment Market Share by Region (2019-2030)

Figure 32. China Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Gene Therapies for Tumor Treatment Market Share by Country (2019-2030)

Figure 40. Mexico Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Country (2019-2030)

Figure 44. Turkey Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Gene Therapies for Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Novartis Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2019-2024)

Figure 47. Gilead Sciences Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2019-2024)

Figure 48. Amgen Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2019-2024)

Figure 49. Shanghai Sunway Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2019-2024)

Figure 50. Sibiono Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2019-2024)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Heavy Ion Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9J14338

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global Radioisotope Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14H14175

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global Microwave Tumor Ablation System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22N12035

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Hematologic Malignancies Detection Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20M14708

Mon Sep 02 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions